加齢性黄斑変性症（AMD）の世界市場：市場規模・現状・予測

• 英文タイトル：Global Wet Age Related Macular Degeneration (AMD) Market Size, Status and Forecast 2019-2025

• レポートコード：QYR9ST05076 • 出版社/出版日：QYResearch / 2019年9月2日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、97ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：医療・製薬

• 販売価格（消費税別）

Single User	￥577,200 (USD3,900)	▷ お問い合わせ
Enterprise License	￥1,154,400 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

※当調査レポートでは、加齢性黄斑変性症（AMD）の世界市場について調査・分析し、加齢性黄斑変性症（AMD）の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（湿性加齢黄斑変性（Wet AMD）、乾燥加齢黄斑変性（Dry AMD））、用途別（> 75歳、> 60歳、> 40歳）、地域別（北米、ヨーロッパ、中国、日本国内、東南アジア、インド、中南米）に区分して市場規模を算出しました。 ・レポートの概要 ・世界の加齢性黄斑変性症（AMD）市場動向 ・主要企業別マーケットシェア ・加齢性黄斑変性症（AMD）の種類別市場規模2014-2019 （湿性加齢黄斑変性（Wet AMD）、乾燥加齢黄斑変性（Dry AMD）） ・加齢性黄斑変性症（AMD）の用途別市場規模2014-2019 （> 75歳、> 60歳、> 40歳） ・加齢性黄斑変性症（AMD）の北米市場：主要企業・種類別/用途別市場規模 ・加齢性黄斑変性症（AMD）のヨーロッパ市場：主要企業・種類別/用途別市場規模 ・加齢性黄斑変性症（AMD）の中国市場：主要企業・種類別/用途別市場規模 ・加齢性黄斑変性症（AMD）の日本国内市場：主要企業・種類別/用途別市場規模 ・加齢性黄斑変性症（AMD）の東南アジア市場：主要企業・種類別/用途別市場規模 ・加齢性黄斑変性症（AMD）のインド市場：主要企業・種類別/用途別市場規模 ・加齢性黄斑変性症（AMD）の中南米市場：主要企業・種類別/用途別市場規模 ・主要企業のプロフィール （Novartis International (Switzerland)、Bayer (Germany)、Acucela (US)、Neurotech Pharmaceuticals (US)、Ophthotech (US)、GlaxoSmithKline (US)、Alimera Sciences (US)、StemCell (Canada)、F. Hoffmann-La Roche (Switzerland)、Regeneron Pharmaceutical (US)、Allergan (Ireland)、Adverum Biotechnologies (US)、Gilead Sciences (US)） ・加齢性黄斑変性症（AMD）の市場規模予測2019-2025 （種類別、用途別、地域別市場予測） ・アナリストの観点・結論 ...

Increased disease burden due to rising geriatric population is one of the major factors driving the growth of the global age-related macular degeneration (AMD) market. This market is expected to surpass a valuation of USD 2,200 Mn by the end of 2023. AMD remains a major cause of central visual loss, effecting close to 10% of people older than 65 years and over 25% of people older than 75 years globally.Increased awareness among people about the condition has influenced the AMD treatment global demand. At the same time, the arrival of off-patent blockbuster drugs is reflecting favorably on the market particularly in third-world countries. This has allowed small-scale drug manufactures to penetrate untapped markets.
In 2018, the global Wet Age Related Macular Degeneration (AMD) market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Wet Age Related Macular Degeneration (AMD) status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Wet Age Related Macular Degeneration (AMD) development in United States, Europe and China.

The key players covered in this study
Novartis International (Switzerland)
Bayer (Germany)
Acucela (US)
Neurotech Pharmaceuticals (US)
Ophthotech (US)
GlaxoSmithKline (US)
Alimera Sciences (US)
StemCell (Canada)
F. Hoffmann-La Roche (Switzerland)
Regeneron Pharmaceutical (US)
Allergan (Ireland)
Adverum Biotechnologies (US)
Gilead Sciences (US)

Market segment by Type, the product can be split into
Wet Age-Related Macular Degeneration (Wet AMD)
Dry Age-Related Macular Degeneration (Dry AMD)

Market segment by Application, split into
>75 Years 
>60 Years 
>40 Years

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Wet Age Related Macular Degeneration (AMD) status, future forecast, growth opportunity, key market and key players.
To present the Wet Age Related Macular Degeneration (AMD) development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Wet Age Related Macular Degeneration (AMD) are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

レポート目次

---

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Wet Age Related Macular Degeneration (AMD) Market Size Growth Rate by Type (2014-2025)
1.4.2 Wet Age-Related Macular Degeneration (Wet AMD)
1.4.3 Dry Age-Related Macular Degeneration (Dry AMD)
1.5 Market by Application
1.5.1 Global Wet Age Related Macular Degeneration (AMD) Market Share by Application (2014-2025)
1.5.2 >75 Years 
1.5.3 >60 Years 
1.5.4 >40 Years
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Wet Age Related Macular Degeneration (AMD) Market Size
2.2 Wet Age Related Macular Degeneration (AMD) Growth Trends by Regions
2.2.1 Wet Age Related Macular Degeneration (AMD) Market Size by Regions (2014-2025)
2.2.2 Wet Age Related Macular Degeneration (AMD) Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities

3 Market Share by Key Players
3.1 Wet Age Related Macular Degeneration (AMD) Market Size by Manufacturers
3.1.1 Global Wet Age Related Macular Degeneration (AMD) Revenue by Manufacturers (2014-2019)
3.1.2 Global Wet Age Related Macular Degeneration (AMD) Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Wet Age Related Macular Degeneration (AMD) Market Concentration Ratio (CR5 and HHI)
3.2 Wet Age Related Macular Degeneration (AMD) Key Players Head office and Area Served
3.3 Key Players Wet Age Related Macular Degeneration (AMD) Product/Solution/Service
3.4 Date of Enter into Wet Age Related Macular Degeneration (AMD) Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global Wet Age Related Macular Degeneration (AMD) Market Size by Type (2014-2019)
4.2 Global Wet Age Related Macular Degeneration (AMD) Market Size by Application (2014-2019)

5 United States
5.1 United States Wet Age Related Macular Degeneration (AMD) Market Size (2014-2019)
5.2 Wet Age Related Macular Degeneration (AMD) Key Players in United States
5.3 United States Wet Age Related Macular Degeneration (AMD) Market Size by Type
5.4 United States Wet Age Related Macular Degeneration (AMD) Market Size by Application

6 Europe
6.1 Europe Wet Age Related Macular Degeneration (AMD) Market Size (2014-2019)
6.2 Wet Age Related Macular Degeneration (AMD) Key Players in Europe
6.3 Europe Wet Age Related Macular Degeneration (AMD) Market Size by Type
6.4 Europe Wet Age Related Macular Degeneration (AMD) Market Size by Application

7 China
7.1 China Wet Age Related Macular Degeneration (AMD) Market Size (2014-2019)
7.2 Wet Age Related Macular Degeneration (AMD) Key Players in China
7.3 China Wet Age Related Macular Degeneration (AMD) Market Size by Type
7.4 China Wet Age Related Macular Degeneration (AMD) Market Size by Application

8 Japan
8.1 Japan Wet Age Related Macular Degeneration (AMD) Market Size (2014-2019)
8.2 Wet Age Related Macular Degeneration (AMD) Key Players in Japan
8.3 Japan Wet Age Related Macular Degeneration (AMD) Market Size by Type
8.4 Japan Wet Age Related Macular Degeneration (AMD) Market Size by Application

9 Southeast Asia
9.1 Southeast Asia Wet Age Related Macular Degeneration (AMD) Market Size (2014-2019)
9.2 Wet Age Related Macular Degeneration (AMD) Key Players in Southeast Asia
9.3 Southeast Asia Wet Age Related Macular Degeneration (AMD) Market Size by Type
9.4 Southeast Asia Wet Age Related Macular Degeneration (AMD) Market Size by Application

10 India
10.1 India Wet Age Related Macular Degeneration (AMD) Market Size (2014-2019)
10.2 Wet Age Related Macular Degeneration (AMD) Key Players in India
10.3 India Wet Age Related Macular Degeneration (AMD) Market Size by Type
10.4 India Wet Age Related Macular Degeneration (AMD) Market Size by Application

11 Central & South America
11.1 Central & South America Wet Age Related Macular Degeneration (AMD) Market Size (2014-2019)
11.2 Wet Age Related Macular Degeneration (AMD) Key Players in Central & South America
11.3 Central & South America Wet Age Related Macular Degeneration (AMD) Market Size by Type
11.4 Central & South America Wet Age Related Macular Degeneration (AMD) Market Size by Application

12 International Players Profiles
12.1 Novartis International (Switzerland)
12.1.1 Novartis International (Switzerland) Company Details
12.1.2 Company Description and Business Overview
12.1.3 Wet Age Related Macular Degeneration (AMD) Introduction
12.1.4 Novartis International (Switzerland) Revenue in Wet Age Related Macular Degeneration (AMD) Business (2014-2019)
12.1.5 Novartis International (Switzerland) Recent Development
12.2 Bayer (Germany)
12.2.1 Bayer (Germany) Company Details
12.2.2 Company Description and Business Overview
12.2.3 Wet Age Related Macular Degeneration (AMD) Introduction
12.2.4 Bayer (Germany) Revenue in Wet Age Related Macular Degeneration (AMD) Business (2014-2019)
12.2.5 Bayer (Germany) Recent Development
12.3 Acucela (US)
12.3.1 Acucela (US) Company Details
12.3.2 Company Description and Business Overview
12.3.3 Wet Age Related Macular Degeneration (AMD) Introduction
12.3.4 Acucela (US) Revenue in Wet Age Related Macular Degeneration (AMD) Business (2014-2019)
12.3.5 Acucela (US) Recent Development
12.4 Neurotech Pharmaceuticals (US)
12.4.1 Neurotech Pharmaceuticals (US) Company Details
12.4.2 Company Description and Business Overview
12.4.3 Wet Age Related Macular Degeneration (AMD) Introduction
12.4.4 Neurotech Pharmaceuticals (US) Revenue in Wet Age Related Macular Degeneration (AMD) Business (2014-2019)
12.4.5 Neurotech Pharmaceuticals (US) Recent Development
12.5 Ophthotech (US)
12.5.1 Ophthotech (US) Company Details
12.5.2 Company Description and Business Overview
12.5.3 Wet Age Related Macular Degeneration (AMD) Introduction
12.5.4 Ophthotech (US) Revenue in Wet Age Related Macular Degeneration (AMD) Business (2014-2019)
12.5.5 Ophthotech (US) Recent Development
12.6 GlaxoSmithKline (US)
12.6.1 GlaxoSmithKline (US) Company Details
12.6.2 Company Description and Business Overview
12.6.3 Wet Age Related Macular Degeneration (AMD) Introduction
12.6.4 GlaxoSmithKline (US) Revenue in Wet Age Related Macular Degeneration (AMD) Business (2014-2019)
12.6.5 GlaxoSmithKline (US) Recent Development
12.7 Alimera Sciences (US)
12.7.1 Alimera Sciences (US) Company Details
12.7.2 Company Description and Business Overview
12.7.3 Wet Age Related Macular Degeneration (AMD) Introduction
12.7.4 Alimera Sciences (US) Revenue in Wet Age Related Macular Degeneration (AMD) Business (2014-2019)
12.7.5 Alimera Sciences (US) Recent Development
12.8 StemCell (Canada)
12.8.1 StemCell (Canada) Company Details
12.8.2 Company Description and Business Overview
12.8.3 Wet Age Related Macular Degeneration (AMD) Introduction
12.8.4 StemCell (Canada) Revenue in Wet Age Related Macular Degeneration (AMD) Business (2014-2019)
12.8.5 StemCell (Canada) Recent Development
12.9 F. Hoffmann-La Roche (Switzerland)
12.9.1 F. Hoffmann-La Roche (Switzerland) Company Details
12.9.2 Company Description and Business Overview
12.9.3 Wet Age Related Macular Degeneration (AMD) Introduction
12.9.4 F. Hoffmann-La Roche (Switzerland) Revenue in Wet Age Related Macular Degeneration (AMD) Business (2014-2019)
12.9.5 F. Hoffmann-La Roche (Switzerland) Recent Development
12.10 Regeneron Pharmaceutical (US)
12.10.1 Regeneron Pharmaceutical (US) Company Details
12.10.2 Company Description and Business Overview
12.10.3 Wet Age Related Macular Degeneration (AMD) Introduction
12.10.4 Regeneron Pharmaceutical (US) Revenue in Wet Age Related Macular Degeneration (AMD) Business (2014-2019)
12.10.5 Regeneron Pharmaceutical (US) Recent Development
12.11 Allergan (Ireland)
12.12 Adverum Biotechnologies (US)
12.13 Gilead Sciences (US)

13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)

14 Analyst’s Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details

List of Tables and Figures

Table Wet Age Related Macular Degeneration (AMD) Key Market Segments
Table Key Players Wet Age Related Macular Degeneration (AMD) Covered
Table Global Wet Age Related Macular Degeneration (AMD) Market Size Growth Rate by Type 2014-2025 (Million US$)
Figure Global Wet Age Related Macular Degeneration (AMD) Market Size Market Share by Type 2014-2025
Figure Wet Age-Related Macular Degeneration (Wet AMD) Figures
Table Key Players of Wet Age-Related Macular Degeneration (Wet AMD)
Figure Dry Age-Related Macular Degeneration (Dry AMD) Figures
Table Key Players of Dry Age-Related Macular Degeneration (Dry AMD)
Table Global Wet Age Related Macular Degeneration (AMD) Market Size Growth by Application 2014-2025 (Million US$)
Figure >75 Years  Case Studies
Figure >60 Years  Case Studies
Figure >40 Years Case Studies
Figure Wet Age Related Macular Degeneration (AMD) Report Years Considered
Table Global Wet Age Related Macular Degeneration (AMD) Market Size 2014-2025 (Million US$)
Figure Global Wet Age Related Macular Degeneration (AMD) Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Wet Age Related Macular Degeneration (AMD) Market Size by Regions 2014-2025 (Million US$)
Table Global Wet Age Related Macular Degeneration (AMD) Market Size by Regions 2014-2019 (Million US$)
Table Global Wet Age Related Macular Degeneration (AMD) Market Share by Regions 2014-2019
Figure Global Wet Age Related Macular Degeneration (AMD) Market Share by Regions 2014-2019
Figure Global Wet Age Related Macular Degeneration (AMD) Market Share by Regions 2019
Table Market Top Trends
Table Global Wet Age Related Macular Degeneration (AMD) Revenue by Manufacturers (2014-2019) (Million US$)
Table Global Wet Age Related Macular Degeneration (AMD) Market Share by Manufacturers (2014-2019)
Figure Global Wet Age Related Macular Degeneration (AMD) Market Share by Manufacturers in 2018
Table Global Wet Age Related Macular Degeneration (AMD) Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Wet Age Related Macular Degeneration (AMD) Product/Solution/Service
Table Date of Enter into Wet Age Related Macular Degeneration (AMD) Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Wet Age Related Macular Degeneration (AMD) Market Size by Type (2014-2019) (Million US$)
Table Global Wet Age Related Macular Degeneration (AMD) Market Size Share by Type (2014-2019)
Figure Global Wet Age Related Macular Degeneration (AMD) Market Size Market Share by Type (2014-2019)
Table Global Wet Age Related Macular Degeneration (AMD) Market Size by Application (2014-2019) (Million US$)
Table Global Wet Age Related Macular Degeneration (AMD) Market Size Share by Application (2014-2019)
Figure Global Wet Age Related Macular Degeneration (AMD) Market Size Market Share by Application (2014-2019)
Figure Global Wet Age Related Macular Degeneration (AMD) Revenue Market Share by Application in 2018
Figure United States Wet Age Related Macular Degeneration (AMD) Market Size 2014-2019 (Million US$)
Table United States Key Players Wet Age Related Macular Degeneration (AMD) Revenue (2018-2019) (Million US$)
Table United States Key Players Wet Age Related Macular Degeneration (AMD) Market Share (2018-2019)
Table United States Wet Age Related Macular Degeneration (AMD) Market Size by Type (2014-2019) (Million US$)
Table United States Wet Age Related Macular Degeneration (AMD) Market Share by Type (2014-2019)
Table United States Wet Age Related Macular Degeneration (AMD) Market Size by Application (2014-2019) (Million US$)
Table United States Wet Age Related Macular Degeneration (AMD) Market Share by Application (2014-2019)
Figure Europe Wet Age Related Macular Degeneration (AMD) Market Size 2014-2019 (Million US$)
Table Europe Key Players Wet Age Related Macular Degeneration (AMD) Revenue (2018-2019) (Million US$)
Table Europe Key Players Wet Age Related Macular Degeneration (AMD) Market Share (2018-2019)
Table Europe Wet Age Related Macular Degeneration (AMD) Market Size by Type (2014-2019) (Million US$)
Table Europe Wet Age Related Macular Degeneration (AMD) Market Share by Type (2014-2019)
Table Europe Wet Age Related Macular Degeneration (AMD) Market Size by Application (2014-2019) (Million US$)
Table Europe Wet Age Related Macular Degeneration (AMD) Market Share by Application (2014-2019)
Figure China Wet Age Related Macular Degeneration (AMD) Market Size 2014-2019 (Million US$)
Table China Key Players Wet Age Related Macular Degeneration (AMD) Revenue (2018-2019) (Million US$)
Table China Key Players Wet Age Related Macular Degeneration (AMD) Market Share (2018-2019)
Table China Wet Age Related Macular Degeneration (AMD) Market Size by Type (2014-20189) (Million US$)
Table China Wet Age Related Macular Degeneration (AMD) Market Share by Type (2014-2019)
Table China Wet Age Related Macular Degeneration (AMD) Market Size by Application (2014-2019) (Million US$)
Table China Wet Age Related Macular Degeneration (AMD) Market Share by Application (2014-2019)
Figure Japan Wet Age Related Macular Degeneration (AMD) Market Size 2014-2019 (Million US$)
Table Japan Key Players Wet Age Related Macular Degeneration (AMD) Revenue (2018-2019) (Million US$)
Table Japan Key Players Wet Age Related Macular Degeneration (AMD) Market Share (2018-2019)
Table Japan Wet Age Related Macular Degeneration (AMD) Market Size by Type (2014-2019) (Million US$)
Table Japan Wet Age Related Macular Degeneration (AMD) Market Share by Type (2014-2019)
Table Japan Wet Age Related Macular Degeneration (AMD) Market Size by Application (2014-2019) (Million US$)
Table Japan Wet Age Related Macular Degeneration (AMD) Market Share by Application (2014-2019)
Figure Southeast Asia Wet Age Related Macular Degeneration (AMD) Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Wet Age Related Macular Degeneration (AMD) Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Wet Age Related Macular Degeneration (AMD) Market Share (2018-2019)
Table Southeast Asia Wet Age Related Macular Degeneration (AMD) Market Size by Type (2014-2019) (Million US$)
Table Southeast Asia Wet Age Related Macular Degeneration (AMD) Market Share by Type (2014-2019)
Table Southeast Asia Wet Age Related Macular Degeneration (AMD) Market Size by Application (2014-2019) (Million US$)
Table Southeast Asia Wet Age Related Macular Degeneration (AMD) Market Share by Application (2014-2019)
Figure India Wet Age Related Macular Degeneration (AMD) Market Size 2014-2019 (Million US$)
Table India Key Players Wet Age Related Macular Degeneration (AMD) Revenue (2018-2019) (Million US$)
Table India Key Players Wet Age Related Macular Degeneration (AMD) Market Share (2018-2019)
Table India Wet Age Related Macular Degeneration (AMD) Market Size by Type (2014-2019) (Million US$)
Table India Wet Age Related Macular Degeneration (AMD) Market Share by Type (2014-2019)
Table India Wet Age Related Macular Degeneration (AMD) Market Size by Application (2014-2019) (Million US$)
Table India Wet Age Related Macular Degeneration (AMD) Market Share by Application (2014-2019)
Figure Central & South America Wet Age Related Macular Degeneration (AMD) Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Wet Age Related Macular Degeneration (AMD) Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Wet Age Related Macular Degeneration (AMD) Market Share (2018-2019)
Table Central & South America Wet Age Related Macular Degeneration (AMD) Market Size by Type (2014-2019) (Million US$)
Table Central & South America Wet Age Related Macular Degeneration (AMD) Market Share by Type (2014-2019)
Table Central & South America Wet Age Related Macular Degeneration (AMD) Market Size by Application (2014-2019) (Million US$)
Table Central & South America Wet Age Related Macular Degeneration (AMD) Market Share by Application (2014-2019)
Table Novartis International (Switzerland) Company Details
Table Novartis International (Switzerland) Revenue in Wet Age Related Macular Degeneration (AMD) Business (2014-2019) (Million US$)
Figure Novartis International (Switzerland) Revenue Growth Rate in Wet Age Related Macular Degeneration (AMD) Business (2014-2019)
Table Novartis International (Switzerland) Recent Development
Table Bayer (Germany) Company Details
Table Bayer (Germany) Revenue in Wet Age Related Macular Degeneration (AMD) Business (2014-2019)(Million US$)
Figure Bayer (Germany) Revenue Growth Rate in Wet Age Related Macular Degeneration (AMD) Business (2014-2019)
Table Bayer (Germany) Recent Development
Table Acucela (US) Company Details
Table Acucela (US) Revenue in Wet Age Related Macular Degeneration (AMD) Business (2014-2019)(Million US$)
Figure Acucela (US) Revenue Growth Rate in Wet Age Related Macular Degeneration (AMD) Business (2014-2019)
Table Acucela (US) Recent Development
Table Neurotech Pharmaceuticals (US) Company Details
Table Neurotech Pharmaceuticals (US) Revenue in Wet Age Related Macular Degeneration (AMD) Business (2014-2019)(Million US$)
Figure Neurotech Pharmaceuticals (US) Revenue Growth Rate in Wet Age Related Macular Degeneration (AMD) Business (2014-2019)
Table Neurotech Pharmaceuticals (US) Recent Development
Table Ophthotech (US) Company Details
Table Ophthotech (US) Revenue in Wet Age Related Macular Degeneration (AMD) Business (2014-2019)(Million US$)
Figure Ophthotech (US) Revenue Growth Rate in Wet Age Related Macular Degeneration (AMD) Business (2014-2019)
Table Ophthotech (US) Recent Development
Table GlaxoSmithKline (US) Company Details
Table GlaxoSmithKline (US) Revenue in Wet Age Related Macular Degeneration (AMD) Business (2014-2019)(Million US$)
Figure GlaxoSmithKline (US) Revenue Growth Rate in Wet Age Related Macular Degeneration (AMD) Business (2014-2019)
Table GlaxoSmithKline (US) Recent Development
Table Alimera Sciences (US) Company Details
Table Alimera Sciences (US) Revenue in Wet Age Related Macular Degeneration (AMD) Business (2014-2019)(Million US$)
Figure Alimera Sciences (US) Revenue Growth Rate in Wet Age Related Macular Degeneration (AMD) Business (2014-2019)
Table Alimera Sciences (US) Recent Development
Table StemCell (Canada) Company Details
Table StemCell (Canada) Revenue in Wet Age Related Macular Degeneration (AMD) Business (2014-2019)(Million US$)
Figure StemCell (Canada) Revenue Growth Rate in Wet Age Related Macular Degeneration (AMD) Business (2014-2019)
Table StemCell (Canada) Recent Development
Table F. Hoffmann-La Roche (Switzerland) Company Details
Table F. Hoffmann-La Roche (Switzerland) Revenue in Wet Age Related Macular Degeneration (AMD) Business (2014-2019)(Million US$)
Figure F. Hoffmann-La Roche (Switzerland) Revenue Growth Rate in Wet Age Related Macular Degeneration (AMD) Business (2014-2019)
Table F. Hoffmann-La Roche (Switzerland) Recent Development
Table Regeneron Pharmaceutical (US) Company Details
Table Regeneron Pharmaceutical (US) Revenue in Wet Age Related Macular Degeneration (AMD) Business (2014-2019)(Million US$)
Figure Regeneron Pharmaceutical (US) Revenue Growth Rate in Wet Age Related Macular Degeneration (AMD) Business (2014-2019)
Table Regeneron Pharmaceutical (US) Recent Development
Table Allergan (Ireland) Company Details
Table Adverum Biotechnologies (US) Company Details
Table Gilead Sciences (US) Company Details
Table Global Wet Age Related Macular Degeneration (AMD) Market Size by Regions (Million US$) 2019-2025
Figure Global Wet Age Related Macular Degeneration (AMD) Market Size Share by Regions (2019-2025)
Figure Global Wet Age Related Macular Degeneration (AMD) Market Size Share by Regions in 2025
Figure United States Wet Age Related Macular Degeneration (AMD) Market Size Forecast (2019-2025)(Million USD)
Figure Europe Wet Age Related Macular Degeneration (AMD) Market Size Forecast (2019-2025)(Million USD)
Figure China Wet Age Related Macular Degeneration (AMD) Market Size Forecast (2019-2025)(Million USD)
Figure Japan Wet Age Related Macular Degeneration (AMD) Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Wet Age Related Macular Degeneration (AMD) Market Size Forecast (2019-2025)(Million USD)
Figure India Wet Age Related Macular Degeneration (AMD) Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Wet Age Related Macular Degeneration (AMD) Market Size Forecast (2019-2025)(Million USD)
Table Global Wet Age Related Macular Degeneration (AMD) Market Size by Product (2019-2025) (Million US$)
Figure Global Wet Age Related Macular Degeneration (AMD) Market Size by Product (2019-2025)
Figure Global Wet Age Related Macular Degeneration (AMD) Market Size by Product in 2025
Table Global Wet Age Related Macular Degeneration (AMD) Market Size by Application (2019-2025) (Million US$)
Figure Global Wet Age Related Macular Degeneration (AMD) Market Size by Application (2019-2025)
Figure Global Wet Age Related Macular Degeneration (AMD) Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

---